Home » Newsletters » BioWorld Science

BioWorld Science

May 30, 2013

View Archived Issues

Respivert presents results for inhaled and intranasal formulations of RV-568

Merck & Co. synthesizes new CGRP receptor antagonists

E.U. funding supports work of SUPPRESSTEM consortium

SBIR grant awarded to Empire Genomics

Early clinical results reported for a novel cell-based gene therapy for melanoma

Amgen and Astellas Pharma establish strategic alliance for Japan

Valneva formed through merger of Vivalis and Intercell

Forest Laboratories presents phase III results for cariprazine in patients with schizophrenia

A novel variable rat model allows evaluation of the effects of ICP on optic neuropathies

Serum TSH levels as predictors of outcome in patients with severe sepsis

GSK and Tempero present novel HDAC9 inhibitors

FDA accepts POZEN's NDA for integrated aspirin therapy

Merck & Co. develops new S. aureus vaccines

Abbott receives license in Canada for RealTime High Risk HPV molecular diagnostic test

ThromboGenics licenses Eleven Biotherapeutics drug technology for diabetic eye diseases

EMA grants orphan drug designation to Sucampo's retinitis pigmentosa therapeutic

Genervon recruits for phase IIa ALS study following FDA clearance

Purdue Pharma patents novel Na(v)1.7 sodium channel blockers

Merck & Co. to return worldwide rights to novel antifungal candidate MK-3118

Janssen and Johnson & Johnson to fund collaboration for neurodegenerative diseases

Alethia and IBC Generium form strategic alliance

Chinese group prepares new PARP inhibitors

FDA approves two new GSK drugs, companion diagnostic for unresectable or metastatic melanoma

NeuroVive provides update on European phase III study of CicloMulsion in reperfusion injury

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...